Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs

WINNERSH, UNITED KINGDOM–(Marketwired – Oct 10, 2014) – Vernalis plc (LSE: VER) today announces it has opened its US office in Berwyn, Pennsylvania and has strengthened its US Executive team with the appointment of Dr Pascal Borderies, as SVP Medical Affairs. A physician by training, Pascal joins Vernalis from Actavis’ subsidiary company Aptalis Pharma, Inc., bringing with him a wealth of clinical and commercial experience, in both prescription (Schering-Plough) and OTC (Novartis Consumer Health) markets. Whilst at Novartis, Pascal was Director – Global Head Cough-Cold Respiratory, Pain and New Growth Opportunities. Pascal will have responsibility for all clinical development, medical affairs, regulatory and pharmacovigilance activities in our commercial and development portfolio.

Source: http://www.marketwired.com/mw/release.do?id=1956465&sourceType=3